key: cord-1045018-0yfrwal6 authors: Timek, Tomasz A. title: Commentary: Whether it's the best of times or the worst of times, it's the only time we've got date: 2020-12-29 journal: JTCVS open DOI: 10.1016/j.xjon.2020.12.007 sha: 73e7411d5cba5931dadf339ad48b923bd9acedca doc_id: 1045018 cord_uid: 0yfrwal6 nan Commentary: Whether it's the best of times or the worst of times, it's the only time we've got Q1 Q5 Tomasz A. Timek, MD, PhD The COVID-19 pandemic has upended life as we know it worldwide in 2020 and has especially challenged health care systems in affected countries. Our specialty of cardiothoracic surgery has not been spared from the wave of ill patients overwhelming hospital wards and intensive care units. However, limited access to treatment of cardiothoracic patients may have dire consequences owing to the potentially high morbidity and mortality of untreated cardiac or pulmonary pathology. The cardiac surgical community has responded with a well-coordinated response defining the early triage procedures in centers most affected in the early stages of the pandemic 1 and rapid reporting of the North American 2 and international 3 experience for guidance. Our European colleagues have likewise "circled the wagons" to provide early descriptions of treatment algorithms from Italy and reporting of national data. In this issue of the Journal, Lopez-Marco and colleagues 5 present a multicenter United Kingdom experience on treatment pathways and outcomes of patients with acute aortic syndromes during the first phase of the pandemic. The authors report maintained access to emergent aortic procedures and similar outcomes as in the prepandemic period. Seven patients in the series were diagnosed with COVID-19, although no deaths were attributable to the infection. A recent study from 2 Chinese centers and the University of Michigan suggested that patients with COVID-19 infection and type A aortic dissection may be at higher risk of mortality, whereas intervention in patients recovered from recent infection may be safe. 6 Two smaller Chinese reports 7,8 during the first phase of the pandemic demonstrated equivalent results to pre-pandemic data, yet in one of the studies, all patients ultimately tested negative for the virus. How COVID-19 status and timing of infection factors into perioperative outcomes of acute aortic syndromes remains unclear, but the lethal nature of this surgical pathology makes the decision making process less complicated, as most centers would not deny surgical intervention based on COVID-19 status. In more elective cardiac surgery cases, the treatment algorithm becomes more troublesome. Fattouch and colleagues 9 reported 15% mortality in cardiac surgery patients who develop COVID-19 during their hospital course, emphasizing the higher-than-expected death rate based on preoperative clinical risk factors. On the other hand, limiting the access of cardiac surgical patients to operative intervention may have significant untoward effects. 10 Lopez-Marco and colleagues provide organizational guidance for treating patients with aortic syndromes in a national health care system during the height of the pandemic, and they should be congratulated on their efforts to maintain clinical access. However, these efforts represent more administrative and organization strategies rather than clinical decision making. The risk-benefit ratio for cardiac surgical patients with less lethal pathologies remains to be clearly defined, as does the influence of the timing of infection on the timing of surgery . 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: insights and clinical strategies from a center at the epicenter COVID-19 North American Cardiac Surgery Survey Working Group. Cardiac surgery in North America and coronavirus disease 2019 (COVID-19): regional variability in burden and impact. J Thorac Cardiovasc Surg Response of cardiac surgery units to COVID-19: an internationally based quantitative survey Italian Society for Cardiac Surgery Task Force on COVID-19 Pandemic. The COVID-19 outbreak and its impact on hospitals in Italy: the model of cardiac surgery The fate of patients with acute aortic syndromes during the COVID-19 pandemic: a UK multicenter study Type A aortic dissection during the COVID-19 pandemic: report from tertiary aortic centers in the United States and China. Q4 Semin Thorac Cardiovasc Surg Early outcomes of Stanford type A aortic dissection under the coronavirus disease 2019 (COVID-19) pandemic: a multicentre study from Hubei province Management of acute type A aortic dissection during COVID-19 outbreak: the Anzhen experience Cardiac surgery outcomes in patients with coronavirus disease 2019 (COVID-19): a case-series report Assessing the collateral damage of the novel coronavirus: a call to action for the post-COVID-19 Era Impact of septal myectomy volume on mitral valve replacement rate in hypertrophic cardiomyopathy patients